Amniotics: Funding Granted to NK-Programme - Redeye
Redeye is optimistic about the grant agreement with the European Innovation Council that will fund an Amniotics-led consortium developing develop natural killer (NK) cells.
ANNONS
Redeye is optimistic about the grant agreement with the European Innovation Council that will fund an Amniotics-led consortium developing develop natural killer (NK) cells.